FDA inspection
Delaware Institute for Reproductive Medicine, P.A: FDA inspection ending Oct 26, 2022
FDA inspection 1187482 · No Action Indicated (NAI) · Newark, DE
Key facts
| Inspection ID | 1187482 |
|---|---|
| Firm | Delaware Institute for Reproductive Medicine, P.A |
| FEI number | 3003939643 |
| Address | 4745 Ogletown Stanton Rd Ste 111 |
| City | Newark |
| State | DE |
| ZIP | 19713 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Oct 26, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data